Mr. Speaker, that is just not true.
From the outset of the pandemic, we knew that we had to expand our domestic biomanufacturing capacity in the short and the long term. That is why we immediately made investments to support projects like Medicago, VIDO-InterNac, the National Research Council Canada and AbCellera.
We acted quickly to increase vaccine manufacturing capacity across the country, and we did so by listening to and following the advice of our scientists and experts every step of the way.